Free Trial

Rapport Therapeutics (RAPP) SEC Filings & 10K Form

Rapport Therapeutics logo
$14.38 -0.25 (-1.71%)
Closing price 04:00 PM Eastern
Extended Trading
$13.20 -1.18 (-8.20%)
As of 04:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Rapport Therapeutics SEC Filings

DateFilerForm TypeView
07/09/2025
11:15 PM
Rapport Therapeutics (Filer)
Form EFFECT
07/09/2025
11:15 PM
Rapport Therapeutics (Filer)
Form EFFECT
07/01/2025
5:55 AM
Rapport Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
07/01/2025
5:51 AM
Rapport Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/18/2025
3:30 PM
Rapport Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2025
3:15 PM
Rapport Therapeutics (Issuer)
Silva Paul M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
3:15 PM
Bredt David (Reporting)
Rapport Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
3:15 PM
PAUL STEVEN M (Reporting)
Rapport Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
3:15 PM
Huber Reid M (Reporting)
Rapport Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
3:15 PM
PEREZ ROBERT J (Reporting)
Rapport Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
3:15 PM
HEALY JAMES (Reporting)
Rapport Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
3:15 PM
MARAGANORE JOHN (Reporting)
Rapport Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
3:15 PM
Rapport Therapeutics (Issuer)
Young Wendy B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
3:15 PM
Rapport Therapeutics (Issuer)
Sanchez Ramiro (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
3:24 PM
Bredt David (Reporting)
Rapport Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/08/2025
6:15 AM
Rapport Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
6:30 AM
Rapport Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/24/2025
5:07 AM
Rapport Therapeutics (Filer)
Form DEF 14A
04/24/2025
5:08 AM
Rapport Therapeutics (Filer)
Form DEFA14A
04/24/2025
5:10 AM
Rapport Therapeutics (Filer)
Form ARS
04/16/2025
4:00 PM
Bredt David (Reporting)
Rapport Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
4:00 PM
Bredt David (Reporting)
Rapport Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2025
3:20 PM
Bredt David (Reporting)
Rapport Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/13/2025
4:13 PM
Ignelzi Troy A. (Reporting)
Rapport Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
6:45 AM
Rapport Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/11/2025
6:30 AM
Rapport Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/11/2025
6:15 AM
Rapport Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/03/2025
6:14 AM
Rapport Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2025
3:15 PM
Rapport Therapeutics (Subject)
Third Rock Ventures V, L.P. (Filed by)
Form SCHEDULE 13G
02/04/2025
4:30 PM
Gault Cheryl (Reporting)
Rapport Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:30 PM
Ceesay Abraham (Reporting)
Rapport Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:30 PM
Bredt David (Reporting)
Rapport Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:30 PM
Rapport Therapeutics (Issuer)
Yeleswaram Krishnaswamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:30 PM
Ignelzi Troy A. (Reporting)
Rapport Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
5:30 AM
Rapport Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
2:11 PM
Cormorant Asset Management, LP (Filed by)
Rapport Therapeutics (Subject)
Form SC 13G/A
11/13/2024
11:26 AM
Capital International Investors (Filed by)
Rapport Therapeutics (Subject)
Form SC 13G
11/12/2024
9:34 AM
FMR LLC (Filed by)
Rapport Therapeutics (Subject)
Form SC 13G/A
11/07/2024
5:59 PM
Rapport Therapeutics (Issuer)
Silva Paul M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2024
6:00 PM
PEREZ ROBERT J (Reporting)
Rapport Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2024
6:00 PM
Rapport Therapeutics (Issuer)
Young Wendy B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Everyone’s watching Nvidia right now. Here’s why I’m excited. (Ad)

So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.

🎯 Click here to watch the video and get the free ticker XGPT just flagged.
11/07/2024
5:35 PM
Rapport Therapeutics (Issuer)
Silva Paul M (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/07/2024
5:45 PM
PEREZ ROBERT J (Reporting)
Rapport Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/07/2024
5:47 PM
Rapport Therapeutics (Issuer)
Sanchez Ramiro (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2024
5:27 PM
Rapport Therapeutics (Issuer)
Young Wendy B. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/07/2024
5:31 PM
Rapport Therapeutics (Issuer)
Sanchez Ramiro (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/07/2024
6:30 AM
Rapport Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
6:15 AM
Rapport Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2024
4:23 PM
JOHNSON & JOHNSON (Filed by)
Rapport Therapeutics (Subject)
Form SC 13G
08/08/2024
6:40 AM
Rapport Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
6:20 AM
Rapport Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:RAPP) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners